HealthcareServices

Global Chronic Lower Back Pain Market Report 2026–2030: Data-Driven Growth Insights

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic lower back pain market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Chronic Lower Back Pain Market in 2030?

The chronic lower back pain market size has experienced consistent expansion in recent years. It is projected to grow from $8.04 billion in 2025 to $8.41 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.6%. The historical growth of this market can be attributed to an increasing aging population, rising prevalence of musculoskeletal disorders, growing sedentary lifestyles, a higher incidence of workplace-related back injuries, and expanded access to diagnostic imaging.

The chronic lower back pain market is anticipated to exhibit sustained expansion over the coming years, with its value projected to reach $10.06 billion by 2030, advancing at a compound annual growth rate (CAGR) of 4.6%. This growth during the forecast period is fueled by factors such as an escalating demand for non-invasive interventions, the increasing embrace of digital therapeutics, the broadening scope of outpatient pain management offerings, a greater emphasis on personalized medicine, and augmented investments in chronic pain research. Noteworthy trends for this period include a wider adoption of multimodal pain management strategies, an increased utilization of minimally invasive procedures, the growing integration of digital instruments for pain monitoring, an expansion of tailored treatment approaches, and a heightened focus on non-opioid pain therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

What Drivers Are Influencing Production Trends In The Chronic Lower Back Pain Market?

The chronic lower back pain market is projected to see growth, influenced significantly by the expanding geriatric population. This group comprises individuals aged 65 years and above. Within this demographic, age-related neurodegenerative and musculoskeletal conditions, such as arthritis and osteoarthritis, accelerate, causing weakness and painful complaints that culminate in chronic back pain and diminished physical activity. To illustrate, in May 2024, the Administration for Community Living, a US-based government agency, revealed that in 2022, 17.3% of the populace had reached 65 years or more. This proportion is forecast to reach 22% by 2040. Consequently, the rising geriatric population is acting as a primary catalyst for the chronic lower back pain market’s expansion.

Which Segments Are Gaining Traction In The Chronic Lower Back Pain Market?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types Of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

What Trends Are Projected To Support The Growth Of The Chronic Lower Back Pain Market?

Leading firms within the chronic lower back pain market are creating offerings that incorporate sophisticated technologies, such as BurstDR SCS technology, to provide patients with novel therapeutic choices. This BurstDR SCS technology represents a unique spinal cord stimulation (SCS) treatment modality, functioning by employing gentle electrical impulses to modify pain signals on their journey from the spinal cord to the brain. An illustrative example is Abbott Laboratories, a medical device company based in the US, which secured FDA approval in May 2023 for its Spinal Cord Stimulation (SCS) devices, specifically the Proclaim SCS Family and Eterna SCS System, intended for managing chronic back pain. These SCS devices from Abbott utilize their patented BurstDR stimulation waveform, an enhanced therapeutic approach crafted to more accurately replicate the transmission of pain signals to the brain and address the emotional distress associated with pain, a departure from conventional tonic stimulation.

Who Are The Primary Competitors In The Global Chronic Lower Back Pain Market?

Major companies operating in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Which Regions Are Projected To Dominate The Chronic Lower Back Pain Market In The Coming Years?

North America was the largest region in the chronic lower back pain market in 2025. The regions covered in the chronic lower back pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Lower Back Pain Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp

Browse Through More Reports Similar to the Global Chronic Lower Back Pain Market 2026, By The Business Research Company

Muscle Pain Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795